within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B05B_IVSolutions.B05BC01_Mannitol;

model Mannitol
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 2.1350000000000003e-06,
    adminDuration = 600,
    adminMass = 500 / 1000000,
    adminCount = 1,
    Vd = 0.00020999999999999998,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Mannitol</td></tr><tr><td>ATC code:</td><td>B05BC01</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>500</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.21</td><td>L</td></tr>
    <tr><td>clearance:</td><td>1.83</td><td>mL/min/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Mannitol is an osmotic diuretic used to reduce intracranial pressure, manage cerebral edema, and promote diuresis in acute renal failure or to excrete toxic substances. It is approved for intravenous use in various acute medical settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult healthy volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>Deferm, N, et al., &amp; Allegaert, K (2021). Glomerular Filtration Rate in Asphyxiated Neonates Under Therapeutic Whole-Body Hypothermia, Quantified by Mannitol Clearance. <i>Clinical pharmacokinetics</i> 60(7) 897–906. DOI:<a href=\"https://doi.org/10.1007/s40262-021-00991-6\">10.1007/s40262-021-00991-6</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33611729/\">https://pubmed.ncbi.nlm.nih.gov/33611729</a></p></li><li><p>Hahn, RG (2023). Isotonic saline causes greater volume overload than electrolyte-free irrigating fluids. <i>Journal of basic and clinical physiology and pharmacology</i> 34(6) 717–723. DOI:<a href=\"https://doi.org/10.1515/jbcpp-2021-0032\">10.1515/jbcpp-2021-0032</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34563101/\">https://pubmed.ncbi.nlm.nih.gov/34563101</a></p></li><li><p>Kaneda, K, et al., &amp; Todd, MM (2010). Pharmacokinetic characteristics of bolus-administered mannitol in patients undergoing elective craniotomy. <i>Journal of clinical pharmacology</i> 50(5) 536–543. DOI:<a href=\"https://doi.org/10.1177/0091270009348973\">10.1177/0091270009348973</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20051588/\">https://pubmed.ncbi.nlm.nih.gov/20051588</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.B.B05BC01 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Mannitol;
